Literature DB >> 18209988

[Long-term results after liver transplantation].

H Schrem1, N Till, T Becker, H Bektas, M P Manns, C P Strassburg, J Klempnauer.   

Abstract

Liver transplantation has been reported to reach excellent results for selected indications. We analysed the results of liver transplantation in our centre over a period of 23 years, with a total of 2,114 consecutive liver transplants in 1,773 patients (eras I-III 5.5 years each, era IV 6.5 years). Overall 20-year survival after liver transplantation was 29.8%. The most frequent leading causes of death were infections of various origins (30%), tumour recurrence (14.2%), and pneumonia (8.4%). The most frequent leading causes for graft loss were infection of various origins (19.6%), initial nonfunction of the graft (14.6%), and tumour recurrence (9.6%). Both long-term patient and graft survival were significantly better after primary liver transplantation than after first retransplantation (P<0.001). Patient and graft long-term survival improved significantly across all four consecutive eras (P<0.001). In era IV, the most recent, 5-year patient survival reached 96% for PBC, 89.4% for PSC, 78.5% for biliary atresia, 70% for acute liver failure, 69.1% for HBV-related cirrhosis, 61.3% for hepatocellular carcinoma, and 56% for HCV-related cirrhosis.

Entities:  

Mesh:

Year:  2008        PMID: 18209988     DOI: 10.1007/s00104-007-1457-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  27 in total

1.  Liver transplantation today.

Authors:  J Klempnauer; H Schrem; T Becker; B Nashan; R Lück
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

Review 2.  Bacterial, mycobacterial, and protozoal infections after liver transplantation--part I.

Authors:  Janis E Blair; Shimon Kusne
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

3.  De novo malignancies following liver transplantation: a case-control study with long-term follow-up.

Authors:  Francis Y Yao; Manjushree Gautam; Caren Palese; Raquel Rebres; Norah Terrault; John P Roberts; Marion G Peters
Journal:  Clin Transplant       Date:  2006 Sep-Oct       Impact factor: 2.863

4.  Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

Authors:  Edward J Gane; Peter W Angus; Simone Strasser; Darrell H G Crawford; John Ring; Gary P Jeffrey; Geoffrey W McCaughan
Journal:  Gastroenterology       Date:  2007-01-05       Impact factor: 22.682

Review 5.  Viral and fungal infections after liver transplantation--part II.

Authors:  Shimon Kusne; Janis E Blair
Journal:  Liver Transpl       Date:  2006-01       Impact factor: 5.799

Review 6.  Update on liver transplantation using cyclosporine.

Authors:  H Schrem; R Lück; T Becker; B Nashan; J Klempnauer
Journal:  Transplant Proc       Date:  2004-11       Impact factor: 1.066

7.  Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry.

Authors:  Masaki Nio; Ryoji Ohi; Takeshi Miyano; Morihiro Saeki; Kazuo Shiraki; Koichi Tanaka
Journal:  J Pediatr Surg       Date:  2003-07       Impact factor: 2.545

8.  Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.

Authors:  Anurag Maheshwari; Hwan Y Yoo; Paul J Thuluvath
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

9.  Long-term results of pediatric liver transplantation: an analysis of 569 transplants.

Authors:  J A Goss; C R Shackleton; S V McDiarmid; M Maggard; K Swenson; P Seu; J Vargas; M Martin; M Ament; J Brill; R Harrison; R W Busuttil
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Retransplantation of the liver in adults: long-term outcome and prognostic modeling.

Authors:  Yasushi Yamauchi; Andre Wettergren; Yuichi Yamashita; Koji Mikami; Masanobu Hyodo; Peter Norgaard Larsen; Allan Rasmussen; Takayuki Shirakusa; Preben Kirkegaard
Journal:  Hepatogastroenterology       Date:  2007-06
View more
  8 in total

Review 1.  [Specific infections in organ transplantation].

Authors:  M Cornberg; B Schlevogt; J Rademacher; A Schwarz; M Sandherr; G Maschmeyer
Journal:  Internist (Berl)       Date:  2016-01       Impact factor: 0.743

Review 2.  Aftercare for patients with transplanted organs.

Authors:  Harald Schrem; Hannelore Barg-Hock; Christian P Strassburg; Anke Schwarz; Jürgen Klempnauer
Journal:  Dtsch Arztebl Int       Date:  2009-02-27       Impact factor: 5.594

3.  Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury.

Authors:  Mohammed Reza Moussavian; Claudia Scheuer; Michael Schmidt; Otto Kollmar; Matthias Wagner; Maximilian von Heesen; Martin K Schilling; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

4.  Technical feasibility of liver transplantation without cold storage.

Authors:  S Gül; F Klein; G Puhl; P Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2013-12-08       Impact factor: 3.445

5.  [Predictive parameters in children with biliary atresia].

Authors:  J Leonhardt; J F Kuebler; C Turowski; R von Wasielewski; E D Pfister; T Becker; B M Ure; C Petersen
Journal:  Chirurg       Date:  2009-07       Impact factor: 0.955

Review 6.  [Liver transplantation: indications and results].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

7.  Perioperative risk factors for prolonged mechanical ventilation after liver transplantation due to acute liver failure.

Authors:  Serin Lee; Hyun Sik Jung; Jong Ho Choi; Jaemin Lee; Sang Hyun Hong; Sung Hyun Lee; Chul-Soo Park
Journal:  Korean J Anesthesiol       Date:  2013-09-25

8.  Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.

Authors:  Johannes Klose; Michelle A Klose; Courtney Metz; Frank Lehner; Michael P Manns; Juergen Klempnauer; Nils Hoppe; Harald Schrem; Alexander Kaltenborn
Journal:  Langenbecks Arch Surg       Date:  2014-06-04       Impact factor: 3.445

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.